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Satellite cellsMuscle stem cells and their progeny play a fundamental role in the regeneration of adult skeletal muscle. We
have previously shown that activation of the canonical Wnt/β-catenin signaling pathway in adult myogenic
progenitors is required for their transition from rapidly dividing transient amplifying cells to more
differentiated progenitors. Whereas Wnt signaling in Drosophila is dependent on the presence of the co-
regulator Legless, previous studies of the mammalian ortholog of Legless, BCL9 (and its homolog, BCL9-2),
have not revealed an essential role of these proteins in Wnt signaling in speciﬁc tissues during development.
Using Cre-lox technology to delete BCL9 and BCL9-2 in the myogenic lineage in vivo and RNAi technology to
knockdown the protein levels in vitro, we show that BCL9 is required for activation of the Wnt/β-catenin
cascade in adult mammalian myogenic progenitors. We observed that the nuclear localization of β-catenin
and downstream TCF/LEF-mediated transcription, which are normally observed in myogenic progenitors
upon addition of exogenous Wnt and during muscle regeneration, were abrogated when BCL9/9-2 levels
were reduced. Furthermore, reductions of BCL9/9-2 inhibited the promotion of myogenic differentiation by
Wnt and the normal regenerative response of skeletal muscle. These results suggest a critical role of BCL9/9-
2 in the Wnt-mediated regulation of adult, as opposed to embryonic, myogenic progenitors.
Published by Elsevier Inc.Introduction
Myogenic stem cells (satellite cells) are the source myogenic
progenitors that are responsible for the successful regeneration of
adult muscle tissue after injury. Upon muscle injury, satellite cells
activate, proliferate and differentiate to form nascent muscle ﬁbers.
Understanding the coordinated lineage progression and molecular
signals that regulate this complex process is of fundamental
importance in understanding tissue regeneration. Wnt signaling
plays an important role in many stem and progenitor cell functions
in various models of tissue and limb regeneration (Kim et al., 2007;
Osakada et al., 2007). Recently, we demonstrated that Wnt/β-catenin
signaling increases in myogenic progenitors during lineage progres-
sion and promotes differentiation of myogenic progenitors inA.S. Brack),
edicine, Harvard University,
, Technologiepark 4, B-9052
Inc.regenerating adult muscle (Brack et al., 2008). Extracellular Wnt
inhibitors, DKK1 and sFRP3, inhibited lineage progression and
differentiation, demonstrating a requirement of Wnt signaling for
effective adult muscle regeneration (Brack et al., 2008). Duringmuscle
development, various Wnts have also been shown to mediate
myogenic commitment and differentiation (Tajbakhsh et al., 1998;
Cossu and Borello, 1999; Anakwe et al., 2003).
The Wnt signaling cascade can be activated through various
ligands, but the hallmark of active canonical Wnt signaling is nuclear
localized β-catenin (Logan and Nusse, 2004). In the nucleus, β-catenin
binds to the TCF/LEF transcription factors to activate downstream
target genes. Loss-of-function studies have demonstrated a require-
ment for β-catenin in satellite cell and myogenic progenitor fate
during development and in the adult (Borello et al., 2006; Brunelli
et al., 2007; Perez-Ruiz et al., 2008).
In Drosophila, transcriptional activation in response to Wnt in-
volves a nuclear protein complex containing armadillo (theDrosophila
homolog of β-catenin) and the co-activators Legless and Pygopus
(Kramps et al., 2002; Parker et al., 2002; Thompson et al., 2002;
Belenkaya et al., 2002). Mutants of legless and pygopus have
phenotypes that are very similar to that of the wingless mutant
(Kramps et al., 2002; Parker et al., 2002; Thompson et al., 2002;
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proteins in the Wnt signaling pathway. Legless and Pygopus act as
transcriptional co-activators, promoting Wnt/β-catenin signaling by
multiplemechanisms (Townsley et al., 2004; Hoffmans et al., 2005; de
la Roche and Bienz, 2007; Carrera et al., 2008). In mammals, there are
two orthologs of Legless (termed BCL9 and BCL9-2) and two orthologs
of Pygopus (termed Pygopus1 and Pygopus2). The roles of these
proteins in the canonical Wnt/β-catenin signaling pathway in
mammals are less well characterized. In vitro studies suggest that
BCL9 and Pygopus may be essential for Wnt/β-catenin signaling only
in very speciﬁc cellular contexts (Thompson et al., 2002; Sustmann
et al., 2008). Mice that are null for Pygopus1 are viable and fertile with
no obvious defects. Mice that are null for Pygopus2 or null for both
Pygopus 1 and 2 die shortly after birth and exhibit reduced TCF-
mediated signaling but have relatively mild developmental pheno-
types (Li et al., 2007; Song et al., 2007; Schwab et al., 2007). Therefore,
unlike in Drosophila, the absence of Pygopus does not phenocopy the
developmental consequences of disrupted Wnt/β-catenin signaling
(Grigoryan et al., 2008). Likewise, mice that are null for both BCL9 and
BCL9-2, although embryonic lethal, also do not phenocopy mice in
whichWnt/β-catenin signaling has been disrupted (MA, unpublished
observations). It should be noted that although divergent roles for
BCL9 and BCL9-2 have been reported (Brembeck et al., 2004), there is
considerable functional redundancy (Brembeck et al., 2004; Hoffmans
and Basler, 2007). Despite the requirement of Legless and Pygopus for
canonical Wnt signaling in Drosophila, the roles of BCL9 and Pygopus
proteins in Wnt signaling in mammals, either during development or
in adult tissue regeneration, remains to be determined.
The study of adult stem cells in tissue homeostasis and repair have
revealed the fact that, although there are many aspects of develop-
ment that are recapitulated when stem cells activate to form new
tissue, there are also features of adult tissue formation following
injury that are not shared by developmental counterparts. For
example, muscle development and maturation is normal in FGF6
null mice, whereas muscle regenerative capacity is severely compro-
mised in the adult (Floss et al., 1997). The divergence in regulatory
control between embryonic and adult progenitors is only accentuated
in the setting of tissue injury in the adult. In that case, stem cells and
progenitors function in an environment that is inﬂuenced by products
of injured, dying, and dead cells, by inﬁltrating inﬂammatory cells and
factors they secrete, by highly dynamic and perhaps even aberrant
extracellular matrix deposition and remodeling, and a host of other
features not present in developing tissue. The study of the role of
evolutionarily conserved signaling pathways, such as the Wnt
pathway, in adult stem cells responding to tissue damage is likely to
reveal the full repertoire of regulatory components of the pathway
that rarely or never come into play during development. Hence it is
essential not only to characterize the role that such signaling
pathways play in the biology of adult stem cells, but alto to determine
the molecular basis that explains how modulations of the pathway
may yield divergent phenotypes during development and during
adult tissue repair.
In the current study, we explore the role of BCL9 in adult muscle
stem cells participating in tissue repair. Using a tissue-speciﬁc
knockout approach, we did not observe any obvious muscle
phenotype in BCL9-null muscle, despite the importance of Wnt
signaling in muscle development (Cossu and Borello, 1999). To our
surprise, however, initial studies revealed a dramatic defect in adult
muscle regeneration. Further analysis demonstrated that BCL9 is
essential for regulating Wnt signaling during speciﬁc stages of adult
muscle stem cell activation. Knocking down BCL9 in vitro and
genetically disrupting BCL9 in vivo both abrogated the Wnt-mediated
promotion of differentiation of adult myogenic progenitors. We
hypothesize that the co-regulators of the Wnt pathway may be
speciﬁcally recruited as part of an ampliﬁcation program that requires
rapid and coordinated stem cell activation, proliferative expansion,and differentiation during tissue repair in response to acute injury.
These ﬁndings may serve as a general model for the understanding
defects in adult stem cell functionality associated with genetic
alterations that yield no signiﬁcant developmental phenotypes.
Materials and methods
Animals
Mutant mice were generated in which BCL9 and BCL9-2 were
simultaneously inactivated by conditional targeting using the Cre-lox
recombination system (MA, unpublished observations). Brieﬂy, a pair
of loxP sites was introduced into intronic sequences ﬂanking exon V of
BCL9 and exons VI and VII of BCL9-2, respectively, leading to loss of the
coding sequences for the β-catenin binding site in BCL9 and the β-
catenin and Pygopus binding sites in BCL9-2. The targeting vectors
were introduced into embryonic stem cells by electroporation, and
single colonies were analyzed for homologous recombination of the
BCL9 and BCL9-2 targeting vector. Correctly targeted clones were
used to generate chimeric founder mice by blastocyst injection. The
founder mice were crossed with FLPeR mice expressing the ﬂp
recombinase gene in the ROSA26 locus to delete the FRT ﬂanked
PGKneo cassette in germ cells. Mice with two copies of BCL9loxP and
BCL9-2loxP were crossed with heterozygous Myf5-Cre mice (Haldar et
al., 2007) to generate mice that were null for BCL9/9-2 in muscle and
control littermates. To monitor efﬁciency of Cre-mediated recombi-
nation, ROSA26-βgal mice (Soriano, 1999) were crossed with Myf5-
Cre mice. Animals were housed and handled in accordance with the
guidelines of Veterinary Medical Unit of the VA Palo Alto Health Care
System and the Administrative Panel on Laboratory Animal Care of
Stanford University.
Reagents
Antibodies to the following proteins used were: Pax7, eMyHC and
MyHC; (A4.1025) (DSHB; Iowa City, IA); β-catenin (Pharmingen/
Beckton-Dickinson, San Jose, CA); MyoD and Myogenin (Santa Cruz,
Santa Cruz, CA); BCL9 (mouse monoclonal; Novus Biologicals,
Littleton, CO). The chicken polyclonal Syndecan-4 antibody was
generously provided by Bradley Olwin (University of Colorado).
Fluorophore secondary conjugates used for immunoﬂuorescence
detection were donkey-anti-chicken Alexa488, goat-anti-mouse
Alexa488, goat-anti-mouse Alexa546, goat-anti-rabbit Alexa488, and
donkey-anti-rat Alexa488 (Invitrogen, Carlsbad, CA). Recombinant
Wnt3A was from R&D Systems (Minneapolis, MN).
Single ﬁber cultures, cell cultures, and satellite cell isolation
Single ﬁber cultures and satellite cell isolations were performed as
described previously (Brack et al., 2007). To measure Wnt-dependent
TCF/LEF luciferase reporter activity, LSL cells were used as described
previously (Blitzer and Nusse, 2006; Brack et al., 2007). Luciferase
activity was normalized to a stably expressed LacZ plasmid.
Silencing of BCL9 and BCL9-2 expression
Two pairs of siRNA oligonucleotides targeting the BCL9 and BCL9-2
transcripts as well as negative control siRNA oligonucleotides (from
Invitrogen, Carlsbad, CA) were used in these studies. One pair was
selected due to a more consistent and higher level of gene silencing.
The sequences were CCTTCCTGGGTTTGCAGGAATGATA and
CCCGGATTTGGAGGTATGCAGAGTA for BCL9 and BCL9-2, respectively.
Myoblasts (isolated and puriﬁed according to standard procedures
(Brack et al., 2008) or LSL cells (Blitzer and Nusse, 2006) were plated
in 6-well plates at either 50% or 90% conﬂuency, respectively, and
transfected 24 h later with siRNA using Lipofectamine 2000
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incubated in proliferation medium (20% fetal bovine serum (FBS;
Mediatech, Hendon, VA) in Hams F-10 (Gibco BRL)) for 24 h and then
analyzed either immediately or after treatment with Wnt3A for 18 h.
Modulation of Wnt signaling in vitro
Single ﬁber cultures were incubated in plating medium (10%
horse serum (HS; Gibco BRL) and 0.5% chick embryo extract (CEE;
US Biological, Swampscott, MA) in Dulbecco's modiﬁed Eagle's
medium (DMEM; Gibco BRL)) for 3 days and then treated with
Wnt3A for 8 h and analyzed for β-catenin localization in growth
medium (10% HS/DMEM). Myoblasts or LSL cells treated with con-
trol or BCL9/9-2 siRNA as described above were switched to growth
medium for 8 h with or without Wnt3A and analyzed for β-catenin,
or for 18 h and analyzed for luciferase activity as described pre-
viously (Brack et al., 2007).
Muscle injury and modulation of Wnt signaling in regenerating muscle
Injury to whole muscle was made by injection of barium chloride
(50 μl, 1.2%) into 30 sites in the lower limb. Focal injuries to TA
muscles were made by applying a metal probe, 4 mm in diameter that
had been cooled on dry ice, directly to the exposed muscle surface for
10 s. To modulate Wnt levels, 10 μl of Wnt3A or control solution was
introduced into the muscle surrounding the injury site by direct
intramuscular injection.
Histology and immunoﬂuorescence
Muscles were dissected and embedded for cryostat sectioning.
Immunoﬂuorescence was performed on 12 μm thick ﬁxed sections
(4% PFA, 10 min) and incubated in MOM blocking solution (Vector
Labs, Burlingame, CA) according to the manufacturer's guidelines.
Sectionswere incubated in eMyHC primary antibody (at 1/5 dilution),
washed and blocked in 5% goat serum (GS) in 0.2% Triton X-100 in PBS
(PBT) and then incubated with ﬂuorophore-conjugated antibody
(Alexa goat anti-mouse546). Immunoﬂuorescence was performed on
ﬁxed cells after permeabilization with 0.2% PBT for 10 min and
blocked with 5% GS in PBT. Cells were incubated in primary antibodies
overnight at 4°C at the following dilutions: Pax7 (1/200), Myogenin
(1/300), MyoD (1/150), β-catenin (1/100), BCL9 (1/150). Cells were
washed and blocked in 5% GS/PBT and then incubated with
ﬂuorophore-conjugated secondary antibody (Alexa goat anti-
mouse546, Alexa goat anti-mouse488, goat anti-rabbit488, or goat
anti-rabbit546 at 1/1500) and DAPI to visualize nuclei for 1 h at room
temperature. β-galactosidase was determined by X-gal staining
(Invitrogen) as described previously (Brack et al., 2007).
Quantiﬁcation of lineage progression and differentiation in vitro
Myogenic cells from single ﬁber cultures were analyzed for the
percentage of cells that expressed Myogenin or MyHC. To measure
morphological differentiation of myogenic cells in fusion medium (3%
HS/DMEM), the Fusion Index was calculated as the ratio of the
number of nuclei present in MyHC+ myotubes (3 or more nuclei)
normalized to the total number of nuclei×100.
Analysis of ﬁber size and ﬁber number in injured area
Images of immunostained serial sections of regenerating muscle
were collected using a 20× objective. The number and cross-sectional
area of every regenerating muscle ﬁber (denoted by central
nucleation and expression of eMyHC) was quantiﬁed in the mid-
region of the injury using Axiovision AC software (Zeiss) and
normalized to cross-sectional areas of adjacent non-injured muscleﬁbers in stained sections. Every eMyHC+ ﬁber within the regenerating
area was counted to reduce selection bias. Three sections were
counted per muscle to minimize sampling errors and any variations in
ﬁber size along the length of ﬁber. A minimum of 3 mice per time-
point within each genotype was analyzed.
Fluorescent activated cell sorting
To enrich for myogenic progenitors, cells were isolated from
myoﬁbers as described above and then puriﬁed by sorting for cells
that express Syndecan-4 (Cornelison et al., 2001). The Syndecan-4
antibody was directly conjugated to IgG-APC using Alexa Fluor647
Monoclonal Antibody Labeling Kit (Invitrogen) according to the
manufacturer's recommendations. Cells were incubated in sorting
medium (10% HS in Hams F-10) for 5 min then incubated in anti-Syn-
4-APC (1/100), anti-CD31-FITC (1/200), and anti-CD45-FITC (1/200)
for 1 h on ice. Cells were washed, centrifuged and re-suspended in
sorting medium. Cells were analyzed using FACS Vantage SE (BD
Biosciences). Cells were sorted with a gating hierarchy of forward and
side scatter and gated to include cells positive for anti-Syn-4-APC and
negative for anti-CD31-FITC and anti-CD45-FITC. A minimum of
20,000 cells were collected per sample. After collection, the cells were
washed, spun and prepared for further analysis.
Real time RT-PCR
RNA was isolated from muscle using TRIZOL reagent (Invitrogen)
and cDNA was synthesized using Superscript First Strand Synthesis
System for RT-PCR (Invitrogen) according to the manufacturer's
instructions. Quantitation by real-time PCR was carried out on a MyiQ
real time PCR (Biorad) using probes against BCL9, BCL9-2, Axin2 and
GAPDH (Applied Biosystems). The quantitation of gene expression
was normalized to GAPDH.
Statistical analysis
A minimum of 3 replicates was done for experiments presented.
Data are presented as means and standard errors of the mean.
Comparisons between groups were done using Kruskall–Wallis
comparison and a Dunn's multiple comparison post hoc test.
Differences were considered statistically signiﬁcant at the pb0.05
level.
Results
To investigate if BCL9 and BCL9-2 are present in satellite cells and
their progeny, tibialis anterior (TA) muscles were either harvested or
injured and left to heal for either 2 or 3.5 days and then harvested.
Myogenic progenitors were isolated and puriﬁed by ﬂow cytometry,
yielding a highly-enriched (97%) population of myogenic cells (SOM
Fig. 1). We observed that the BCL9 transcript was low in satellite cells
and increased during myogenic lineage progression (Fig. 1A).
Conversely, BCL9-2 transcript did not change duringmyogenic lineage
progression in vivo. The expression of BCL9 was also tested at the
protein level using immunohistochemical analysis of satellite cells
and their progeny in single ﬁber cultures (Fig. 1B). Cells were stained
for Syndecan-4 (a satellite cell marker), MyoD (a marker of
proliferating myogenic progenitors), and Myogenin (a marker of
differentiation commitment). During satellite cell activation (18 h to
1.5 days after isolation), BCL9 protein was detected in the cytoplasm
of Syndecan-4+ satellite cells.
After 3 days in growth medium (when a proportion of cells are
committing to differentiation), BCL9 was detected in the nuclei of
Myogenin+ progenitors. By contrast, BCL9 was not present in the
nuclei of multi-nucleated myotubes and instead was localized to the
cytoplasm with a punctuate pattern (Fig. 1C). These data suggest
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progression, initially cytoplasmic in proliferating progenitors, shift-
ing to the nuclei of differentiating progenitors, and then reverting
back to a cytoplasmic localization in differentiated post-mitotic
myotubes (Fig. 1D). The localization of BCL9 in the nuclei of
myogenic progenitors occurs in the same phase as the peak of Wnt
signaling during the differentiation of proliferating progentiors(Brack et al., 2008). Therefore, the nuclear localization of BCL
parallels that of β-catenin.
We next tested whether BCL9 and BCL9-2 mediate Wnt/β-catenin
signaling in myogenic progenitors. Primary myoblasts were treated
with control siRNA or siRNA against BCL9 and BCL9-2 in combination.
Absolute and relative levels of BCL9 and BCL9-2 transcripts were
determined by quantitative real-time RT-PCR. BCL9 and BCL9-2
transcripts were reduced to b15% of control levels by treatment
with targeting siRNAs (Fig. 2A). We analyzed two readouts of Wnt/β-
catenin signaling in siRNA-treated myoblasts: the abundance of Axin2
transcript, a downstream Wnt target (Jho et al., 2002), and nuclear
localization of β-catenin. In myoblasts treated with BCL9/9-2 siRNA,
Axin2 levels were dramatically reduced compared to those in controls
(Fig. 2B). In proliferating myoblasts, β-catenin was rarely detected in
nuclei, indicative of low endogenous Wnt signaling in the population
as reported previously (Brack et al., 2007). In the presence of Wnt3A,
an increased fraction of cells had detectable nuclear β-catenin staining
compared to untreated cells (Fig. 2C), indicating an activation of the
canonicalWnt signaling cascade. In cells treatedwith BCL9/9-2 siRNA,
exogenous Wnt3A did not induce nuclear translocation of β-catenin
(Fig. 2C). Furthermore, Axin2 induction by exogenous Wnt3A was
reduced in BCL9/9-2 siRNA treated cells compared to control cells
(Fig. 2D). Together these data indicate BCL9/9-2 is an essential
mediator of canonical Wnt/β-catenin signaling in adult myogenic
progenitors.
To investigate a more general role of BCL9/9-2 in TCF/LEF-
mediated transcription, we used the LSL cell line, a mammalian
ﬁbroblast line harboring a stable reporter that provides a readout of
Wnt-mediated TCF/LEF-dependent transcription (Blitzer and Nusse,
2006; Brack et al., 2007). LSL cells were transfected with either control
or BCL9/9-2 siRNA and then exposed to control medium or medium
containing Wnt3A. In BCL9/9-2 siRNA treated cells, the Wnt3A-
mediated increase in reporter activity was blocked (Fig. 2E). These
data demonstrate that the essential role of BCL9/9-2 in the Wnt/β-
catenin signaling pathway is not limited to myogenic progenitors but
may include cells derived from other adult tissues. The effect of the
inhibition of Wnt signaling on myogenic differentiation is considered
below.
As an alternative approach to investigate whether BCL9/9-2 is
essential for Wnt/β-catenin signaling, we generated myogenic
progenitors in which the BCL9 and BCL9-2 genes were deleted. Mice
in which BCL9 and BCL9-2 were ﬂanked by loxP sites (MA, unpub-
lished observations) were crossed with Myf5-Cre mice (Haldar et al.,
2007) to delete BCL9 and BCL9-2 speciﬁcally in Myf5-expressing
muscle cells. To assess Cre-dependent recombination in muscle cell
populations, Myf5-Cre mice were crossed with ROSA26-βgal reporter
mice (Soriano, 1999), thereby providing an estimate the percentage of
satellite cells that expressedMyf5 at some point in their history by the
expression of β-gal. We observed that approximately 96% of satellite
cells and their progeny from adult skeletal muscle had robust
expression of β-gal (SOM Fig. 2). Any inefﬁciency of Cre expression
from the Myf5 locus or any inefﬁciency of recombination in Cre-
expressing cells would render that number an underestimate.Fig. 1. BCL9 and BCL9-2 expression inmyogenic progenitors during lineage progression.
(A) Transcript levels of BCL9 (left panel) and BCL9-2 (right panel) assessed by real-time
qRT-PCR analysis of satellite cells (0 days after injury) and their progeny (2 and 3.5 days
after muscle injury) obtained by FACS sorting. Transcript levels were normalized to
GAPDH and expressed relative to day 0. (⁎pb0.05) (B) Representative images of single
muscle ﬁbers incubated for different times after isolation. Various antibodies (to
Syndecan-4 (Syn-4), MyoD, and Myogenin (Myog)) were used in combination with an
antibody against BCL9. Nuclei were visualized with DAPI. (C) Cells incubated in growth
medium for 3 days were subsequently switched to differentiation medium for 2.5 days
to facilitate myotube formation and analyzed for BCL9 and Myogenin expression. (D)
Quantitative analysis of BCL9 immunohistochemistry as shown in panel B and C.
Histogram shows the percentage of myogenic cells with BCL9 expression detectable in
the nucleus after different times in growth or differentiation conditions.
Fig. 2. BCL9/9-2 mediates canonical Wnt signaling in myogenic progenitors. (A) Transcript levels of BCL9 and BCL9-2 were assessed by real-time qRT-PCR analysis of primary
myoblasts after treatment with control siRNA or with siRNA against BCL9 and BCL9-2 in combination. (Average Ct values for Controls: GAPDH—16.7; BCL9—29.2; BCL9-2—26.6;
average Ct values for BCL9/9-2 RNAi-treated: GAPDH—16.6; BCL9—32.4; BCL9-2—29.1). Transcript levels were normalized to GAPDH and expressed relative to control siRNA treated
myoblasts. (⁎pb0.01) (B) Transcript levels of Axin2 in primary myoblasts treated as in Panel A. Transcript levels were normalized to GAPDH and expressed relative to control siRNA
treated myoblasts. (⁎pb0.01) (C) Representative images are shown of immunohistochemistry of β-catenin in primary myoblasts. Primary myoblasts were treated with BCL9/9-2
siRNA or control siRNA and subsequently withWnt3A (40 ng/ml) or control (0.2% BSA) solution for 8 h in growthmedium (arrows indicate β-catenin+ nuclei). Quantitative analysis
of the percentage of cells with nuclear localized β-catenin is shown below. (⁎pb0.05) (D) Transcript levels of Axin2 in primary myoblasts treated withWnt3A after addition of either
BCL9/9-2 or control siRNA. Transcript levels were normalized to GAPDH and expressed relative to control siRNA treated myoblasts. (⁎pb0.05) (E) Wnt reporter activity in LSL cells
transfected with control or BCL9/9-2 siRNA subsequently treated with Wnt3A (20 ng/ml) or control solution for 18 h. Data are expressed as relative luciferase activity (⁎pb0.05).
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suitable for loss-of-function studies in postnatal muscle stem cells and
their progeny.We observed that only 8% of myogenic cells obtained from Myf5-
Cre,BCL9 lox/lox,BCL9-2 lox/loxmice and puriﬁed by ﬂow cytometry were
positive for BCL9 expression compared with more than 90% from
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Wnt/β-catenin signaling, we puriﬁed myogenic cells by ﬂow
cytometry, maintained them for 2 days in culture, and then incubatedFig. 3. Loss of BCL9/9-2 function in muscle cells in vivo alters canonical Wnt signaling in my
null muscle after FACS sorting and maintained in culture for 18 h. Cells were stained for
progenitors FACS-puriﬁed from control and BCL9/9-2 null muscle, maintained in culture for
panel shows β-catenin co-localization with MyoD and DAPI in the nucleus. (C) Quantitative
catenin from studies as in panel B. (⁎pb0.01).them in growth medium in the presence or absence of Wnt3A for 8 h.
In the control myogenic cells, β-cateninwas detected in the nucleus of
33% of cells (Figs. 3B, C). However, in the “BCL9/9-2 null” myogenicogenic progenitors. (A) Puriﬁed satellite cells were obtained from control and BCL9/9-2
MyoD and BCL9. (B) Representative images showing β-catenin in activated myogenic
18 h, and then maintained in the presence or absence of Wnt3A for 8 h. Inset in central
analysis of the percentage of activated myogenic progenitors with nuclear localized β-
Fig. 4. Loss of BCL9/9-2 impairs the commitment to myogenic differentiation in vitro. (A) Single ﬁbers were isolated from BCL9/9-2 null and control muscles and cultured for 2 or
3 days in plating medium. BrdU was added for the ﬁnal 7 h and cells were immunostained with anti-BrdU and anti-Desmin antibodies. Quantitative analysis is shown as the
percentage of BrdU+/Desmin+ cells (⁎pb0.05). (B) Myogenic progenitors from single ﬁber cultures were incubated in plating medium for 3 days, switched to differentiation
medium for 8 h, and immunostained for Desmin andMyogenin (Myog). Quantitative analysis is shown as the percentage of Desmin+ cells expressingMyogenin in control and BCL9/
9-2 null progenitors. (⁎pb0.05) (C) Myogenic progenitors from single ﬁber cultures were switched to differentiation medium for 2 days in the absence (upper panels) or presence
(lower panels) of Wnt3A (40 ng/ml). Cultures were immunostained for Myogenin (green) and MyHC (red). DAPI (blue) stains all nuclei. (D) Quantitative analysis of cells from (C).
Histograms represent the percentage of Myogenin+ cells and the Fusion Index during differentiation in the absence (left panels) and presence (right panels) of Wnt3A. (⁎pb0.05;
⁎⁎pb0.01) (E) At different times in differentiationmedium, the Fusion Index was determined in primarymyoblast cultures after treatment with either a control or BCL9/9-2 siRNA in
combination. A minimum of 500 cells counted per condition. (⁎pb0.05; ⁎⁎pb0.01).
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that observed in control cells in the absence of Wnt3A. Therefore, loss
of BCL9/9-2 prevents the nuclear localization of β-catenin in
myogenic cells normally induced by Wnt3A.
We previously demonstrated that Wnt3A promotes lineage
progression and differentiation of myogenic progenitors (Brack
et al., 2008). The inability to activate Wnt/β-catenin signaling in
BCL9/9-2 null myogenic progenitors led us to investigate the role ofFig. 5. Loss of BCL9/9-2 impairs muscle regeneration in vivo. Cross sections of regeneratin
muscle (null) (right panels). (A) Sections were stained with H&E for histological analysis. (
analyses of the number of regenerating ﬁbers normalized to cross-sectional area (left hi
histogram) in control and BCL9/9-2 null muscles after 4 and 6 days of regeneration. (C) Se
number of Pax7+ cells normalized to total (DAPI+) number of nuclei in the regenerating
Quantitative analysis of the number of BrdU+ cells normalized to total (DAPI+) number
regeneration (right histogram). (D) TUNEL staining of muscle cross sections 4 days after in
number of nuclei in the regenerating area of muscle in WT and null muscles after 4 days oBCL9/9-2 in myogenic lineage progression. We ﬁrst analyzed
proliferation of myogenic progenitors from single muscle ﬁber
cultures using BrdU incorporation. Cultures treated with the Wnt
inhibitor DKK1 showed a dose-dependent increase in BrdU incorpo-
ration, consistent with the role of Wnt inhibiting proliferation and
promoting differentiation (SOM Fig. 3). The percentage of myogenic
cells that incorporated BrdU was similar in BCL9/9-2 null and control
cultures at 2 d (Fig. 4A). Between 2 and 3 days in culture when cellsg TA muscle 4 days after freeze injury in control (WT) (left panels) and BCL9/9-2 null
B) Sections were stained with eMHC to identify newly formed myotubes. Quantitative
stogram) and the average size of nascent muscle ﬁbers in regenerating tissue (right
ctions stained with Pax7 to identify satellite cell progeny. Quantitative analysis of the
area of muscle in WT and null muscles after 4 days of regeneration (left histogram).
of nuclei in the regenerating area of muscle in WT and null muscles after 4 days of
jury. Quantitative analysis of the number of TUNEL+ cells normalized to total (DAPI+)
f regeneration represented in histogram. (⁎pb0.05).
Fig. 5 (continued).
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a decline in cells incorporating BrdU in control cultures. However, in
BCL9/9-2 null myogenic progenitors, there was no decline in BrdU
incorporation at this time.
To address whether BCL9/9-2 plays an important role in Wnt-
mediated myogenic differentiation, we analyzed the differentiation of
myogenic progenitors in which BCL9/-2 had been knocked down by
RNAi or knocked out by Cre-mediated recombination. We ﬁrst
analyzed the expression of Myogenin in BCL9/9-2 null and control
progenitors incubated in differentiation medium. In control cultures,
40% of cells expressed Myogenin after 8 h of differentiation, whereas
only 24% of BCL9/9-2 null myogenic cells expressed Myogenin
(Fig. 4B), a difference that persisted when cells were exposed to
differentiation medium for up to 2 days (Fig. 4C). To assess whether
BCL9/9-2 null myogenic cells were altered in their ability to
terminally differentiate, cultures maintained in differentiation medi-
um for 2 days were analyzed for the expression of Myosin Heavy
Chain (MyHC) and for fusion. In BCL9/9-2 null cultures, fewer cells
expressed MyHC and fewer cells underwent fusion compared to
control cultures (Figs. 4C, D). Furthermore, the promotion of terminal
differentiation byWnt3Awas nearly completely abrogated in BCL9/9-
2 null cultures (Figs. 4C, D). Likewise, the fusion of myogenic
progenitors in which BCL9/9-2 had been knocked down by RNAi
showed an even greater inhibition compared to control cells (Fig. 4E).
Therefore either reducing levels of BCL9/9-2 by RNAi or genetically
deleting BCL9/9-2 expression inhibits active Wnt/β-catenin signaling
and impairs the ability of myogenic cells to commit to differentiation
in vitro.To conﬁrm that these results in vitro reﬂected the behavior of
myogenic cells in vivo, we injured control and BCL9/9-2 null muscles
and allowed the muscles recover for either 4 or 6 days. In BCL9/9-2
null muscles, there appeared fewer and smaller caliber multinucle-
ated myoﬁbers based on histological analysis (Figs. 5A, B). We
observed a markedly reduced number of nascent ﬁbers (identiﬁed by
the expression of embryonic Myosin Heavy Chain (eMyHC), a myosin
gene expressed in newly form myoﬁbers but not in mature ﬁbers) in
BCL9/9-2 null muscles compared to control muscles, and the ﬁbers
were of smaller caliber at both 4 and 6 days of regeneration (Fig. 5B).
These in vivo data support the in vitro data and are consistent with the
requirement for BCL9/9-2 in myogenic progenitors for their commit-
ment to differentiation during muscle regeneration.
To determine whether the regeneration defects in the absence of
BCL9/9-2 are associated with a reduction in the proliferation of
myogenic progenitors, we injected mice with BrdU following injury
and subsequently stained sections for BrdU and Pax7. The number of
Pax7+ and BrdU+ cells in regenerating muscle was not signiﬁcantly
affected by disruption of BCL9/9-2 function (Fig. 5C).We also assessed
the survival of myogenic progenitors in the absence of BCL9/9-2 by
TUNEL staining of sections of regenerating muscle. There was a signiﬁ-
cant increase in the number of TUNEL+ cells in BCL9/9-2 null muscles
compared to controlmuscles (Fig. 5D). Thedata suggest that disrupting
BCL9/9-2 function does not limit differentiation by inhibiting prolif-
eration but rather by promoting apoptosis of myogenic progenitors.
The promotion of myogenic differentiation by Wnt signaling in
vivo (Brack et al., 2008) was also markedly suppressed by the absence
of BCL9/9-2. Wnt3A or vehicle was injected intramuscularly 3 days
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were analyzed 1 day later. In the absence of exogenous Wnt3A, the
regenerating BCL9/9-2 null muscle had fewer myotubes and those
myotubes were smaller in size compared to littermate controls
(Figs. 6A, B). Control muscles injected with Wnt3A showed an
accelerated differentiation and fusion resulting in larger myotubes,
consistent with our previous ﬁndings (Brack et al., 2008). However, in
BCL9/9-2 null muscles injected with Wnt3A, the myotube number
and size was not signiﬁcantly different from vehicle-injected muscles
(Fig. 6B). Thus, the absence of BCL9/9-2 inhibits myogenic differen-
tiation mediated by exogenous Wnt.
Discussion
In the present study, we have used loss-of-function approaches
to analyze the effects of reductions in the mammalian orthologs ofFig. 6.Wnt3A requires BCL9/9-2 in myogenic progenitors to accelerate myogenic differentia
treated with eitherWnt3A (10 μl of 60 ng/ml) or control solution (10 μl of 0.1% BSA) 3 days af
analyses of average size of nascent muscle ﬁbers in regenerating tissue 4 days after injury (lef
and BCL9/9-2 null muscles in presence or absence of Wnt3A. (⁎pb0.05; ⁎⁎pb0.01).Legless (BCL9 and its homolog BCL9-2) in postnatal myogenesis.
Reconstitution of mammalian BCL9 and BCL9-2 into Drosophila
legless mutants showed a functional redundancy between the two
homologs (Hoffmans and Basler, 2007). However in the context of
zebraﬁsh, BCL9 could not compensate for the loss of BCL9-2
function, suggesting functional differences between the two BCL9
homologs (Brembeck et al., 2004). In the present study, to
circumvent possible redundancy between BCL9 and BCL9-2, both
genes were targeted. Further studies will be required to resolve the
speciﬁc cellular and developmental contexts that under which the
two homologs can substitute for one another or not. We show that
BCL9/9-2 is required for the activation of the canonical Wnt
pathway in a mammalian stem cell population, revealing an
evolutionary conservation of this pathway in this context.
Furthermore, we have also demonstrated a critical functional role
of BCL9/9-2 within adult myogenic progenitors for their Wnt-tion in vivo. (A) Muscles from adult (4 months) control and BCL9/9-2 null muscle were
ter injury and analyzed one day later. Sections were stained for eMyHC. (B) Quantitative
t panel) and number of regenerating ﬁbers (right panel) in regenerating tissue in control
103A.S. Brack et al. / Developmental Biology 335 (2009) 93–105mediated commitment to differentiation and effective muscle
regeneration.
In Drosophila, legless was identiﬁed in a genetic screen based on a
phenocopy of the wingless mutant, with epistatic experiments indi-
cating its function was at the level or downstream of β-catenin
(Kramps et al., 2002). Wnt signaling appears almost completely
dependent on both Legless and Pygopus in Drosophila (Clevers, 2006),
where these two proteins bind to TCF and β-catenin in the nucleus to
fully activate canonical Wnt signaling (Kramps et al., 2002; Parker
et al., 2002; Thompson et al., 2002; Hoffmans and Basler, 2004;
Townsley et al., 2004; Hoffmans et al., 2005; Stadeli and Basler, 2005).
BCL9/Legless appears to function as an adaptor protein, providing a
molecular link between Pygopus and β-catenin (Stadeli and Basler,
2005), but BCL9/Legless and Pygopus may function independently of
one another and each has intrinsic transactivation activity (Hoffmans
et al., 2005; de la Roche and Bienz, 2007; Sustmann et al., 2008).
Recently, it was shown that Pygopus may also promote gene
transcription by binding to the Med12 and Med13 subunits of the
Drosophila mediator complex (Carrera et al., 2008).
In vertebrates, the roles of BCL9 and Pygopus in theWnt/β-catenin
signaling pathway are less clear. Over-expression studies in mamma-
lian cells have shown that BCL9 and Pygopus are sufﬁcient to elevate
Wnt/β-catenin signaling in vitro (Brembeck et al., 2004; Townsley
et al., 2004; Sustmann et al., 2008). Knock-down experiments have
demonstrated a requirement for BCL9 and Pygopus in the nuclear
localization of β-catenin in somemammalian cell lines and a functional
requirement of BCL9 in mesoderm patterning (a Wnt8A-mediated
process) in zebraﬁsh (Thompson et al., 2002; Brembeck et al., 2004).
Deletion of Pygopus2 leads to mild developmental defects in some,
but not all, Wnt-dependent tissues, and the defects appear to be
independent of the Wnt signaling pathway (Li et al., 2007; Song et al.,
2007; Schwab et al., 2007). Deletion of both Pygopus genes in mice
leads to defects in kidney development without an abrogation of
TCF/LEF-dependent signaling, and no skeletal muscle phenotype was
observed despite a reduction of TCF/LEF-dependent signaling in
somites (Schwab et al., 2007). The deletion of BCL9 results in
embryonic lethality, whereas mice that are null for BCL9-2 die shortly
after birth, but neither exhibit marked defects in Wnt-dependent
developmental processes (MA, unpublished observations). Mice that
are deﬁcient in both genes die even earlier than BCL9 null mice, but
again without a clear Wnt phenotype. Therefore Wnt regulation of
mammalian development does not appear to be dependent on these
co-activators that are so essential for Wnt signaling during Droso-
phila development.
The ﬁnding that BCL9 is an essential co-activator of the Wnt
pathway, at least for the promotion of differentiation, in adult
myogenic progenitors highlights the point that adult stem cells may
depend on similar signaling pathways as their embryonic counter-
parts but that the regulation of these pathways, as well as their
transcriptional outputs, may differ. Given the different environments
in which embryonic and adult stem and progenitors reside, it is not
surprising that their responses to environmental cues would differ.
Adult stem and progenitor cells are involved in tissue homeostasis
and repair in the context of a fully developed organism and a
completely different systemic milieu than the embryo, perhaps
necessitating additional levels of control of cellular response to
activating or repressive stimuli.
It will be interested to determine which of the pleiotropic effect of
Wnt in adult stem cells, even within cells of a particular lineage (see
below), may be due to differential requirements of co-activators. In
that sense, the studies of this report analyze Wnt-mediated
differentiation of proliferation progenitors in the context of tissue
injury. This is a condition of rapid, synchronous activation of stem
cells followed by coordinated and synchronous differentiation
associated with very high levels of Wnt signaling (Brack et al.,
2008). As such, the speciﬁc requirement for BCL9/9-2 during repair ofacute tissue injury may be as an “ampliﬁcation factor”, whereas the
more gradual cellular responses during development or tissue
homeostasis may not have such a requirement. The other data that
are consistent with this notion are the in vitro data of BLC9 and
Pygopus requirement for Wnt signaling (Thompson et al., 2002;
Sustmann et al., 2008). The cellular response to growth conditions in
vitro aremore likely to reﬂect the kind of acute stress and activation of
tissue injury where the normal tissue environment is disrupted, and
this may explain why co-activator dependence of the Wnt pathway is
observed in culture but not from the corresponding cells and tissues in
vivo during development.
In myogenic cells, ligands in the Wnt/β-catenin pathways, such as
Wnt1 and Wnt3A, can promote differentiation of proliferating
myogenic progenitors in vitro and in vivo (Rochat et al., 2004; Brack
et al., 2008). The fact that the ability of Wnt3A to promote myogenic
differentiation is abrogated in the absence of BCL9/9-2 in myogenic
progenitors suggests that this effect is mediated through the Wnt/β-
catenin cascade. Loss of BCL9/-2 leads to an approximately 40%
reduction in the number and size of regenerating myoﬁbers in vivo. It
is possible that myogenic progenitors are capable of entering the
myogenic differentiation program in a Wnt/β-catenin-independent
manner, albeit less efﬁciently. Wnt ligands have been shown to
inﬂuence numerous signaling pathways besides the Wnt/β-catenin
cascade, such as the NFAT, FGF and BMP pathways (Katoh and Katoh,
2007). It is possible that other pathways cooperate with the Wnt
cascade to co-ordinate differentiation and when Wnt/β-catenin
signaling is compromised, such pathways will initiate myogenic
differentiation with reduced efﬁcacy.
We have not examined the responses to other Wnts under the
same conditions, either other members of the Wnt family that
typically activate the canonical pathway or Wnts that typically
activate non-canonical Wnt signaling cascades. However, it remains
to be determined whether BCL9/9-2 is required for all of the
pleiotropic actions of Wnt on stem/progenitor cells in postnatal
myogenesis, even for the canonical Wnt/β-catenin pathway. For
example, we have previously described that exposure of resting
satellite cells to Wnt can induce a change in fate from a myogenic
lineage to a ﬁbrogenic lineage (Brack et al., 2007). Furthermore, in
other recent studies, it was reported that activation of the Wnt/β-
catenin pathway can, on the one hand, promote self-renewal
(Perez-Ruiz et al., 2008) and, on the other hand, promote
proliferative expansion (Kitzmann et al., 1998). We did not
investigate whether self-renewal was directly affected by BCL9/9-
2 in vivo, however when we analyzed regenerating muscle for the
satellite cell marker, Pax7, we did not observe any differences in the
number of Pax7 cells between control and BCL9/9-2 null muscle.
However direct comparisons of the results are difﬁcult because
different in vitro and in vivo conditions were used. For example,
different approaches to activate the Wnt pathway were used, such
as the addition of ligand to the medium and the overexpression of
β-catenin. Clearly, these are not equivalent. Equally importantly, the
state of the satellite cells at the time of activation of the Wnt
pathway ranged from quiescent to actively proliferating. It is
possible that each stage of satellite cell activation represents a
speciﬁc state during which activation of the Wnt cascade has a
unique cellular consequence compared to any other stage. This
could be achieved through many differences in cellular context,
including the expression of different Wnt receptors in different
populations or the involvement of speciﬁc co-activators such as
BCL9 at different stages of myogenic lineage progression. Such
pleiotropic, even opposing, effects of Wnt in cells of a single lineage
are not unprecedented. The apparently opposing views as to
whether Wnt signaling promotes or inhibits cardiogenesis was
reconciled when the answer was found to be both, depending on
the time of Wnt signaling during cardiogenesis in zebraﬁsh or
during cardiogenic differentiation of ES cells (Ueno et al., 2007). The
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but with such divergent outcomes remains to be determined. In
view of recent studies highlighting the role of the BCL9/Pygopus
complex in specifying the transcriptional read out of active Wnt
signaling (Fiedler et al., 2008), it would be interesting to compare
histone modiﬁcations of Wnt target genes in myogenic progenitors
at different stage along the myogenic lineage. It is possible that the
histone code, as read by the BCL9/Pygopus complex, determines the
transcriptional read out and divergent phenotypic consequences of
activation of the Wnt/β-catenin pathway.
We have used a muscle speciﬁc promoter, Myf5, to drive the
expression of Cre recombinase and delete BCL9 and BCL9-2 in
myogenic progenitors. The Myf5 locus is expressed in myogenic
progenitors during development and in quiescent and activated
satellite cells in the adult (Cornelison and Wold, 1997; Kassar-
Duchossoy et al., 2005; Bajard et al., 2006). Using a ROSA26-βgal
reporter mouse to determine Myf5-Cre recombination efﬁciency, we
observed β-gal in 100% of adult muscle ﬁbers and in 96% of satellite
cells and activated myogenic progenitors. β-gal in the adult muscle
ﬁbers reﬂects cells that had expressed Myf5 at some time in their
developmental history and contributed to the development of the
adult muscle ﬁbers, possibly from the Myf5+ myoblasts in the
myotome which give rise to the majority of the limb muscles (Kassar-
Duchossoy et al., 2005; Bajard et al., 2006; Haldar et al., 2007). Using
YFP as a reporter of Myf5-Cre recombination, Kuang et al. (2007)
reported that 90% of satellite cells have passed through a Myf5+ stage
during their development. This discrepancy (90% vs 96%) between the
YFP and β-gal reporter may be related to issues of sensitivity or to the
fact that the two Myf5-Cre strains were independently generated and
may have subtle differences in expression patterns. With such high
recombination efﬁciency in satellite cells, their progeny and adult
muscle ﬁbers, Myf5-Cre mouse is a useful tool to delete genes in a
tissue-speciﬁc manner. However, it will be important to ascertain
whether cells that are negative for reporter genes in these systems are
a result of inefﬁciencies in all the steps necessary for reporter gene
expression (Cre expression, recombination, transcription at the
reporter gene locus) or truly reﬂect a developmental history that
does not involve expression of the Myf5 locus.
In summary, the fact that BCL9 is required for activation of the
canonical Wnt/β-catenin signaling cascade in Drosophila and in a
mammalian system suggests BCL9 maybe a central component of a
conserved mechanism for ﬁne tuning the amount and/or duration of
Wnt/β-catenin signaling, not only through its presence but also its
cellular location, in speciﬁc cellular contexts. In turn, this may control
the numerous functional properties of stem cells and their progeny
during tissue regeneration which depend on the activation canonical
Wnt signaling pathway. BCL9 proteins may act as ampliﬁers of Wnt
signaling under such cellular contexts when rapid activation and
cessation of the pathway are necessary for temporal control of cell fate
decisions.
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